In this study, our main findings demonstrate that HO-1 is associated with increased Gas6 expression in MM patients, and inhibition of HO-1 enhances sensitivity to bortezomib in myeloma cells via suppressing Gas6 expression and secretion. Here, HMOX1 is linked to plasma cell myeloma.